Sanofi, Lexicon to Collaborate on Sotagliflozin, a Potential Diabetes Treatment
November 06, 2015 at 04:21 AM EST
Sanofi (NYSE: SNY) and Lexicon Pharmaceuticals, Inc. (NASDAQ: LXRX) announced today that they have entered into a collaboration and ...